fludarabine has been researched along with Franklin Disease in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arima, H; Imai, Y; Inoue, D; Kiuchi, M; Maruoka, H; Matsushita, A; Mori, M; Nagano, S; Oita, T; Tabata, S; Takahashi, T; Takiuchi, Y; Yamashiro, A | 1 |
Abboudi, Z; Agrawal, S; Catovsky, D; Matutes, E | 1 |
del Potro Gómez, E; Morales Sanz, D | 1 |
1 review(s) available for fludarabine and Franklin Disease
Article | Year |
---|---|
[Multiple myeloma and other plasma cell dyscrasias].
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Child; Diagnosis, Differential; Heavy Chain Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Melphalan; Multiple Myeloma; Paraproteinemias; Prednisone; Prognosis; Time Factors; Vidarabine; Waldenstrom Macroglobulinemia | 1999 |
2 other study(ies) available for fludarabine and Franklin Disease
Article | Year |
---|---|
Successful treatment of γ-heavy-chain disease with rituximab and fludarabine.
Topics: Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Heavy Chain Disease; Humans; Lymphoma, B-Cell; Male; Rituximab; Vidarabine; Waldenstrom Macroglobulinemia | 2012 |
First report of fludarabine in gamma-heavy chain disease.
Topics: Aged; Antineoplastic Agents; Follow-Up Studies; Heavy Chain Disease; Humans; Male; Vidarabine | 1994 |